BioSpace News Archive

Business

Vir and GSK Team Up with Eli Lilly for Double Monoclonal Antibody Study

Vir Biotechnology, Eli Lilly and GlaxoSmithKline struck a three-way collaborative deal to evaluate its investigational monoclonal antibody, VIR-7831, in combination with Lilly’s bamlanivimab in low-risk patients with mild to moderate COVID-19.

January 27, 2021
·
3 min read
·
Alex Keown
Policy

UPDATE: Bomb Threat Forces Evacuation of AstraZeneca COVID-19 Vaccine Manufacturing Plant

Police have sealed off the area, according to the report. Few details were available, but eye witnesses said a robot was investigating a suspicious package found at the plant.

January 27, 2021
·
2 min read
·
Alex Keown
Business

J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?

At the annual J.P. Morgan conference, the biotech industry launched its encore to a wildly successful 2020 – virtually. And, as is becoming the common scenario, attendees found both pros and cons to our new (temporary?) reality.

January 27, 2021
·
5 min read
·
Heather McKenzie
Business

Money on the Move: January 21-26

A brief rundown of who’s raking in cash in the biopharma world.

January 27, 2021
·
3 min read
·
Kate Goodwin
Career Advice

How to Make a New Co-Worker Feel Like a Part of the Team

Use these ways to immediately make the a new co-worker feel at ease.

January 27, 2021
·
2 min read
·
Laura Brothers
Business

Renowned Surgeon Luis A. Fernandez, MD, Named Loyola Medicine Division Chief, Intra-Abdominal Transplantation

Luis A. Fernandez, MD, FACS, is the new division chief, intra-abdominal transplantation at Loyola Medicine. Dr. Fernandez is a world-renowned transplant surgeon specializing in pancreas, liver, islet cell and renal transplantation.

January 27, 2021
·
5 min read
Deals

Catalyst Biosciences Announces Pricing of Public Offering of Common Stock - Jan 27, 2021

Catalyst Biosciences, Inc. announced the pricing of an underwritten public offering of 8,700,000 shares of its common stock, offered at a price of $5.75 per share to the public.

January 27, 2021
·
4 min read
BioForest

Lumen Bioscience Receives CARB-X Award to Develop Preventative for Deadly Diarrheal Diseases and Details Broad Potential of Spirulina Platform

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drug candidates for highly prevalent diseases, today announced initiation of an up to $14.5 million project funded by CARB-X to develop an oral monoclonal antibody cocktail to prevent serious diarrheal diseases.

January 27, 2021
·
4 min read
Drug Development

Scholar Rock Presents Preclinical Data for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced a presentation at the 2021 TGFβ for Immuno-Oncology Drug Development Summit.

January 27, 2021
·
4 min read
Deals

Sunshine Biopharma Completes Application to Uplist to OTCQB

Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has successfully completed and submitted the application to uplist to the OTCQB.

January 27, 2021
·
4 min read